Ossianix
1 known investors
Ossianix develops TXP1, a brain-selective shuttle based on a deimmunised VNAR antibody scaffold that targets TfR1 to carry therapeutic payloads across the blood-brain barrier. The company focuses on improving delivery of central nervous system therapeutics to the brain.
Founders & leadership
FS
Frank S WalshCEO (Founder)
JL
J Lynn RutkowskiCSO (Founder)
SM
Steve MooreCOO
PS
Pawel StockiVP Research
Investors · 1
Frequently asked questions
- What does Ossianix do?
- Ossianix develops TXP1, a brain-selective shuttle based on a deimmunised VNAR antibody scaffold that targets TfR1 to carry therapeutic payloads across the blood-brain barrier. The company focuses on improving delivery of central nervous system therapeutics to the brain.
- Who founded Ossianix?
- Ossianix was founded by Frank S Walsh, J Lynn Rutkowski.
- Who are Ossianix's investors?
- Ossianix's investors include BioAdvance.